CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-13 | Krishnan Krish S President and CEO | Sale 10b5-1 | −1,331 | $179.55 | $239K | 1,463,711 |
| 2025-02-28 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +5,000 | 17,604 | ||
| 2025-02-28 | ROMANO KATHRYN Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −2,315 | $179.25 | $415K | 15,289 |
| 2025-02-28 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +7,500 | 22,789 | ||
| 2025-02-28 | ROMANO KATHRYN Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −3,471 | $179.25 | $622K | 19,318 |
| 2025-02-28 | ROMANO KATHRYN Chief Accounting Officer | Option exercise · Performance Stock Units 10b5-1 | −5,000 | 0 | ||
| 2025-02-28 | ROMANO KATHRYN Chief Accounting Officer | Option exercise · Performance Stock Units 10b5-1 | −7,500 | 7,500 | ||
| 2025-02-28 | ROMANO KATHRYN Chief Accounting Officer | Grant or award · Stock Option (Right to Buy) 10b5-1 | +10,000 | 10,000 | ||
| 2025-02-28 | ROMANO KATHRYN Chief Accounting Officer | Grant or award · Restricted Stock Units 10b5-1 | +2,200 | 2,200 | ||
| 2025-02-28 | Krishnan Suma President, R&D | Option exercise | +7,500 | 1,480,096 | ||
| 2025-02-28 | Krishnan Suma President, R&D | Shares withheld for taxes | −3,471 | $179.25 | $622K | 1,476,625 |
| 2025-02-28 | Krishnan Suma President, R&D | Option exercise | +22,500 | 1,499,125 | ||
| 2025-02-28 | Krishnan Suma President, R&D | Shares withheld for taxes | −10,414 | $179.25 | $1.9M | 1,488,711 |
| 2025-02-28 | Krishnan Suma President, R&D | Option exercise | +12,500 | 1,549,762 | ||
| 2025-02-28 | Krishnan Suma President, R&D | Shares withheld for taxes | −5,786 | $179.25 | $1.0M | 1,543,976 |
| 2025-02-28 | Krishnan Suma President, R&D | Option exercise | +8,750 | 1,552,726 | ||
| 2025-02-28 | Krishnan Suma President, R&D | Shares withheld for taxes | −4,050 | $179.25 | $726K | 1,548,676 |
| 2025-02-28 | Krishnan Suma President, R&D | Option exercise | +26,250 | 1,574,926 | ||
| 2025-02-28 | Krishnan Suma President, R&D | Shares withheld for taxes | −12,149 | $179.25 | $2.2M | 1,562,777 |
| 2025-02-28 | Krishnan Suma President, R&D | Option exercise · Performance Stock Units | −7,500 | 0 |
Page 14 of 42 · 828 trades